The end targets of this pathway, IL-6, IL-1α and IL-1β, and IL-8 cytokines, presented increased expression in the mesenchymal subtype, and they have also been associated to tumor malignancy and tumor cell migration [22, 47–49]. The gene discussed is IL6; the disease is neoplasm.